Vimarsana
Biggest News Aggregation in the World

Page 5 - Clinical Effectiveness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Effectiveness Today - Breaking & Trending Today

AG awards $50M in opioid settlement funds to ACH - Vimarsana News

AG awards $50M in opioid settlement funds to ACH

Arkansas Attorney General Tim Griffin is awarding $50 million of opioid settlement funds to Arkansas Children’s to pioneer one of the nation’s most ambitious research efforts dedicated to opioids’ impact

Arkansas Advocate : Arkansas Children's establishes center investigating opioids' effect on kids | Regional News - Vimarsana News

Arkansas Advocate : Arkansas Children's establishes center investigating opioids' effect on kids | Regional News

Arkansas Children’s is creating a $70-million center focused on opioids’ impact on children, officials announced last week.

$70M opioid study center planned for Arkansas Children's Hospital, AG Tim Griffin announces | The Arkansas Democrat-Gazette - Vimarsana News

$70M opioid study center planned for Arkansas Children's Hospital, AG Tim Griffin announces | The Arkansas Democrat-Gazette

Arkansas Attorney General Tim Griffin said Thursday he had awarded $50 million from the state's opioid settlement funds to create an Arkansas Children's Hospital research center dedicated to studying the impact of opioids on children.

$70M opioid study center planned for Arkansas Children's Hospital, AG Tim Griffin announces - Vimarsana News

$70M opioid study center planned for Arkansas Children's Hospital, AG Tim Griffin announces

Arkansas Attorney General Tim Griffin said Thursday he had awarded $50 million from the state's opioid settlement funds to create an Arkansas Children's Hospital research center dedicated to studying the impact of opioids on children.

Rx Rundown: Biogen, Novartis, Arbutus Biopharma and more - Vimarsana News

Rx Rundown: Biogen, Novartis, Arbutus Biopharma and more

Check out this week’s medical marketing news, people on the move and industry chatter.